Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published Date:

Abstract

OBJECTIVE: We sought to develop Artificial Intelligence (AI) based models to predict non-transplantable recurrence (NTR) of hepatocellular carcinoma (HCC) following hepatic resection (HR).

Authors

  • Abdullah Altaf
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Yutaka Endo
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Muhammad M Munir
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Muhammad Muntazir M Khan
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Zayed Rashid
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Mujtaba Khalil
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Alfredo Guglielmi
    Department of Surgery, University of Verona, Verona, Italy.
  • Francesca Ratti
    Division of Hepatobiliary Surgery, IRCCS San Raffaele Hospital, Milano, Italy. Electronic address: ratti.francesca@hsr.it.
  • Hugo Marques
    UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.
  • François Cauchy
    Department of HPB Surgery and Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, France.
  • Vincent Lam
    Department of Surgery, Westmead Hospital, Sydney, NSW, Australia.
  • George Poultsides
    Department of Surgery, Stanford University, Stanford, CA, United States.
  • Minoru Kitago
    Department of Surgery, Keio University, Tokyo, Japan.
  • Irinel Popescu
    Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Guillaume Martel
    Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
  • Ana Gleisner
    Department of Surgery, University of Colorado, Aurora, CO, United States.
  • Tom Hugh
    Department of Surgery, The University of Sydney, School of Medicine, Sydney, NSW, Australia.
  • Feng Shen
    Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Itaru Endo
    Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
  • Timothy M Pawlik
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, Columbus, OH.